The Unseen Scar: Why HIV Silently Wounds the Gut Long After Treatment Starts

For a significant portion of individuals managing HIV, contemporary therapeutic interventions effectively suppress the virus, leading to substantial enhancements in overall health. Nevertheless, even with successful viral containment, persistent damage to the intestinal tract stemming from the infection may continue, fostering chronic inflammatory responses implicated in severe health complications. A recent investigation originating from Tulane University, detailed in JCI Insight, offers valuable insights into the underlying mechanisms driving this phenomenon.

The research team ascertained that prolonged exposure to antiretroviral therapies did not fully reinstate critical immune functionalities responsible for safeguarding and restoring the integrity of the gut lining. Furthermore, the study yielded preliminary evidence suggesting that dietary components derived from cruciferous vegetables, such as broccoli and cabbage, might play a role in bolstering immune activities essential for intestinal repair.

This endeavor, spearheaded by Namita Rout, an associate professor of microbiology and immunology at the Tulane National Biomedical Research Center, involved scrutinizing intestinal alterations in nonhuman primates infected with SIV, a pathogen closely analogous to HIV and frequently utilized as a model for HIV infection, subjected to extended antiretroviral treatment regimens. Despite the therapeutic success in curtailing viral replication, the researchers identified ongoing indicators of intestinal barrier impairment, alongside disruptions in pivotal immune cells that are instrumental in maintaining a healthy gut epithelium.

Among these crucial cells were gamma delta T cells and innate lymphoid cells. These cell types typically orchestrate the production of signaling molecules that facilitate intercellular communication, thereby contributing to the protection of the intestinal lining and promoting tissue regeneration. In the treated animal cohort, these protective mechanisms were observed to be diminished, correlating with modifications in proteins that govern the immune activities required for preserving the intestinal barrier’s structural integrity.

Subsequently, the researchers explored the potential for dietary interventions to modulate this specific biological pathway. A select group of the primate subjects was administered a broccoli-derived supplement formulated to increase their intake of indoles, compounds naturally abundant in vegetables like broccoli and cabbage. Following a one-month period, these animals exhibited markers indicative of improved intestinal barrier function and shifts in immune cell demographics associated with mucosal repair processes.

It is imperative to note that these findings do not establish the efficacy of such supplements as a direct treatment for individuals living with HIV, and the study’s scope was restricted to a limited animal sample. However, the outcomes do suggest that a fundamental biological pathway involved in maintaining intestinal equilibrium may retain responsiveness even after prolonged antiretroviral therapy.

This investigation enhances our comprehension of why intestinal damage and persistent chronic inflammation can endure even when the virus is effectively managed. These discoveries pinpoint an immune pathway that appears to be of significant importance for intestinal well-being and could potentially inform future nutritional strategies designed to optimize long-term health outcomes for individuals affected by HIV.

Namita Rout, associate professor of microbiology and immunology, Tulane National Biomedical Research Center

Financial backing for this research was provided by the National Institutes of Health, including grants from the National Institute of Diabetes and Digestive and Kidney Diseases, as well as the Tulane National Biomedical Research Center’s base grant, P51OD011104.